Please Wait
Applying Filters...
menu
    • menu
    CDMO Activity Tracker: Bora, PolPharma make acquisitions; Evonik, EUROAPI, Porton announce technological expansions

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Nov 2024: Trump’s HHS pick drags down jab makers’ stocks; Novartis, Merck, Roche ink billion-dollar deals

    Stock Recap
    #PipelineProspector

    Menu

    Rifaximin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 234Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    26/09/2024 EUROAPI
    France
    		 EUROAPI ITALY S. r. l. 226MF10147 Rifaximin 2014-09-01 2014-09-01 Via Angelo Titi, 22/26, Zona ex punto franco, 72100 Brindisi, Italy
    26/09/2024 F.I.S. Fabbrica Italiana Sintetici
    Italy
    		 F. I. S. Fabrica Italiana Sintetici S. p. A. 226MF10165 Rifaximin 2014-09-01 2016-05-06 Viale Milano 26 36075 Montecchio Maggiore Vicenza, Italy